Introduction
Venous thromboembolism remains a widespread global problem that occurs not only in elderly patients, but also in younger individuals [1]. Most patients receive conservative treatment for deep vein thrombosis (DVT), but 20–50% of them will develop post-thrombotic syndrome (PTS) as a consequence [2]. To prevent such a complication, in selected cases an endovascular procedure followed by a stent implantation is required, especially in cases involving compression syndromes. Mechanical thrombectomy and local thrombolysis possibly reduce the severity of symptoms and the incidence of PTS. In addition, placement of the stent can reduce outflow obstruction and decrease possibility of DVT in the future [3].
Case presentation
An 18-year-old man was admitted to the hospital with massive swelling and pain in the left leg. The patient reported that he had fallen on the floor in the evening, and he noticed the symptoms after he woke up the following morning. After the primary diagnostic process Doppler ultrasound (DUS) was performed, which confirmed DVT. Due to his young age, extensive symptoms, and suspicion of iliac vein thrombosis raised in DUS, computed tomography phlebography was performed. Computed tomography phlebography revealed no contrast in the common iliac vein, external iliac vein, internal iliac vein, femoral vein, and great saphenous vein on the left side, presented in Figures 1A–D. The common iliac vein, external iliac vein, and femoral vein were dilated to diameters, respectively, of 15 mm, 22 mm, and 22 mm. Additionally, the compression of the right common iliac artery on the left iliac vein was visualized, which indicated May-Thurner syndrome. Initially, a heparin infusion was applied. The next day the decision was made to treat this thrombosis with endovascular procedure. The procedure was performed under general anaesthesia with the patient positioned on his abdomen. The position enabled access through the popliteal vein. A 6F sheath was introduced to the popliteal vein, and guidewires were passed through the thrombus to the inferior vena cava. Venography shown on Figures 2A, B confirmed deep vein thrombosis. The guidewire was converted to a stiff guidewire and an AngoJet Solent Omni catheter was introduced. Afterwards mechanical thrombectomy was performed using the AngioJet system. To achieve a superior result, 20 mg of Actilyse was administered. After 20 minutes another mechanical thrombectomy was performed beginning in the femoral vein and finishing in the inferior vena cava. Partial patency was achieved. Next, the aspiration of the thrombus was performed using an 8F sheath, but the result was suboptimal, with obstruction of the iliac vein in the place of common iliac artery compression. The sheath was changed to 10F as the stent implantation was required in left common iliac vein. A Bentley Beyond Venous 16 × 100 mm stent was implanted; however, stenosis of the vein led to damage of the stent. Presumably the rupture of the stent meshes at the stenosis occurred, which is shown in Figure 3B. For appropriate outflow a Sinus- XL 16 × 60 mm stent was implanted into the first stent with subsequent post dilation using an AtlasGold 16 × 40 mm balloon. Proper outflow was observed, but the thrombus was found in the external iliac vein, which was provided with a Sinus Venous 14 × 60 mm stent implantation. Again, balloon dilation, using an AtlasGold 14 × 60 mm, of the Sinus Venous stent and balloon dilation of the femoral vein using an AtlasGold 10 × 80 mm was applied. The result of the procedure is shown on Figures 3A–C. Control phlebography was performed, and the procedure was ended by leaving the 6F sheath in the popliteal vein with administration of Actilyse for 24 hours. Venography (Figures 4A–C) performed the next day revealed an optimal result with very good outflow. What is more, the patient reported pain relief and the leg swelling decreased. The patient was released home the next day with a recommendation of 3 months of anticoagulation therapy. The patient returned after 30 days for a control DUS and examination. The Doppler ultrasound and examination revealed no obstruction in the left venous system and full relief of the symptoms.
Discussion
The popularity of invasive and percutaneous treatment is increasing, especially in symptomatic patients [4]. The improvement of mechanical thrombectomy devices and development of the technique have enabled completion of therapy in a single hospital stay, using minimal amount of thrombolytics, shorter time of the procedure, shorter hospital stay, and lower treatment costs. What is more, clinical and technical success is achieved in the majority of patients, with acceptable safety of the procedure [5].
Stenting of iliofemoral vein stenosis is characterized by decreased morbidity and mortality; in addition, high long-term patency rates are observed [6]. The first time that stenting following DVT was reported was by Berger et al. [7]. Since then stenting has been found to be a sufficient and effective method of treatment of May-Thurner syndrome, which was confirmed in a recent multicentre study that evaluated acute and long-term results [8]. It was also observed that using stents dedicated to veins leads to increased patency rates because venous stents, compared to arterial devices, have greater diameter and lower radial force, which affects the venous wall patency, and they have a low restenosis rate. Additionally, venous stents are associated with proper diameter, flexibility, crush resistance, radial strength, and the possibility of precise implantation [9]. Many anticoagulant and antiplatelet treatment tactics have been described in the literature; however, no guidelines for therapy after vein stenting in vein occlusions have been established [10]. Nevertheless, after analysis of experts’ opinions, it can be stated that in the case of long stent implantations, a long anticoagulation strategy should be applied [11].
Conclusions
Endovascular recanalization of the iliofemoral vein thrombosis is technically possible, safe, and durable. Successful reconstruction using stent implantation in patients presenting with symptoms might significantly improve their clinical state. Stenting in May-Thurner syndrome may lead to complications such as stent rupture, but those complications can be treated successfully.
The authors declare no conflict of interest.
References
1. Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 1973; 48: 839-846.
2.
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
3.
Breen K. Role of venous stenting for venous thromboembolism. Hematology 2020; 2020: 606-611.
4.
Kakkos SK, Gohel M, Baekgaard N, et al. Editor’s choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 2021; 61: 9-82.
5.
Kim BJ, Chung HH, Lee SH, et al. Single-session endovascular treatment for symptomatic lower extremity deep vein thrombosis: a feasibility study. Acta Radiol 2010; 51: 248-255.
6.
Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007; 46: 979-990.
7.
Berger A, Jaffe JW, York TN. Iliac compression syndrome treated with stent placement. J Vasc Surg 1995; 21: 510-514.
8.
Funatsu A, Anzai H, Komiyama K, et al. Stent implantation for May-Thurner syndrome with acute deep venous thrombosis: acute and long-term results from the ATOMIC (AcTive stenting for May-Thurner Iliac Compression syndrome) registry. Cardiovasc Interv Ther 2019; 34: 131-138.
9.
Massi I, Zamboni P. What are the ideal characteristics of a venous stent? Veins Lymphat 2021; 10.
10.
Attaran RR, Ozdemir D, Lin IH, Mena-Hurtado C, Lansky A. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: factors associated with stent occlusion. J Vasc Surg Venous Lymphat Disord 2019; 7: 527-534.
11.
Milinis K, Thapar A, Shalhoub J, Davies AH. Antithrombotic therapy following venous stenting: International Delphi Consensus. Eur J Vasc Endovasc Surg 2018; 55: 537-544.